The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice

• Published in: mBio Vol. 10; no. 5
• Main Authors: Kiouptsi, Klytaimnistra, Jäckel, Sven, Pontarollo, Giulia, Grill, Alexandra, Kuijpers, Marijke J E, Wilms, Eivor, Weber, Christian, Sommer, Felix, Nagy, Magdolna, Neideck, Carlos, Jansen, Yvonne, Ascher, Stefanie, Formes, Henning, Karwot, Cornelia, Bayer, Franziska, Kollar, Bettina, Subramaniam, Saravanan, Molitor, Michael, Wenzel, Philip, Rosenstiel, Philip, Todorov, Hristo, Gerber, Susanne, Walter, Ulrich, Jurk, Kerstin, Heemskerk, Johan W M, van der Vorst, Emiel P C, Döring, Yvonne, Reinhardt, Christoph
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 22.10.2019
• Subjects: Animals; arterial thrombosis; atherothrombosis; carotid artery; Chemokine CCL7 - genetics; Chemokine CCL7 - metabolism; Chemokine CXCL1 - genetics; Chemokine CXCL1 - metabolism; Female; Gastrointestinal Microbiome - genetics; Gastrointestinal Microbiome - physiology; germfree; gut microbiota; Host-Microbe Biology; low-density lipoprotein receptor; Male; Mice; Mice, Mutant Strains; Microbiota - genetics; Microbiota - physiology; Plaque, Atherosclerotic - genetics; Plaque, Atherosclerotic - metabolism; Receptors, LDL - deficiency; Receptors, LDL - genetics; atherosclerosis; microbiota; germfree; low-density lipoprotein receptor; atherothrombosis; vascular inflammation; arterial thrombosis; carotid artery; gut microbiota; platelets
• ISSN: 2161-2129; 2150-7511
• DOI: 10.1128/mBio.02298-19

Atherosclerotic plaque development depends on chronic inflammation of the arterial wall. A dysbiotic gut microbiota can cause low-grade inflammation, and microbiota composition was linked to cardiovascular disease risk. However, the role of this environmental factor in atherothrombosis remains undefined. To analyze the impact of gut microbiota on atherothrombosis, we rederived low-density lipoprotein receptor-deficient ( ) mice as germfree (GF) and kept these mice for 16 weeks on an atherogenic high-fat Western diet (HFD) under GF isolator conditions and under conventionally raised specific-pathogen-free conditions (CONV-R). In spite of reduced diversity of the cecal gut microbiome, caused by atherogenic HFD, GF mice and CONV-R mice exhibited atherosclerotic lesions of comparable sizes in the common carotid artery. In contrast to HFD-fed mice, showing no difference in total cholesterol levels, CONV-R mice fed control diet (CD) had significantly reduced total plasma cholesterol, very-low-density lipoprotein (VLDL), and LDL levels compared with GF mice. Myeloid cell counts in blood as well as leukocyte adhesion to the vessel wall at the common carotid artery of GF mice on HFD were diminished compared to CONV-R controls. Plasma cytokine profiling revealed reduced levels of the proinflammatory chemokines CCL7 and CXCL1 in GF mice, whereas the T-cell-related interleukin 9 (IL-9) and IL-27 were elevated. In the atherothrombosis model of ultrasound-induced rupture of the common carotid artery plaque, thrombus area was significantly reduced in GF mice relative to CONV-R mice. , this atherothrombotic phenotype was explained by decreased adhesion-dependent platelet activation and thrombus growth of HFD-fed GF mice on type III collagen. Our results demonstrate a functional role for the commensal microbiota in atherothrombosis. In a ferric chloride injury model of the carotid artery, GF C57BL/6J mice had increased occlusion times compared to colonized controls. Interestingly, in late atherosclerosis, HFD-fed GF mice had reduced plaque rupture-induced thrombus growth in the carotid artery and diminished thrombus formation under arterial flow conditions.